Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial — Stella

Home/Ischemia Reperfusion Injury/NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

View on ClinicalTrials.gov

Recruiting

Back to Ischemia Reperfusion Injury trials

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Kaiser Permanente San Francisco Medical Center, San Francisco, California

Key details

Phase

Safety & dosing

Sponsor

Kaiser Permanente

Collaborators

National Heart, Lung, and Blood Institute (NHLBI), Beth Israel Deaconess Medical Center

Enrollment target

~304 participants

Started

September 2021

Primary completion

April 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.